The following are current screening recommendations for CDKN2A mutation carriers:
Melanoma
• Annual total body skin examination with a dermatologist
This examination should include baseline and annual follow-up photographs of  moles, if needed, and biopsy and/or removal of suspicious moles
• Monthly self-skin examination
Mutation carriers should be taught how to conduct these exams
Pancreatic cancer
• No standard guidelines
• Mutation carriers should consider screening beginning at age 50 or ten years prior to the youngest known diagnosis of pancreatic cancer in their family
• Current recommended screening protocol include:
Imaging of the pancreas with endoscopic ultrasound and/or MRI
Other recommendations
• First-degree relatives should be referred for genetic counseling and testing.
Table 4: Management recommendations for CDKN2A/p16 mutation carriers.